Neurotherapeutics, 2018 · DOI: https://doi.org/10.1007/s13311-018-0637-0 · Published: June 11, 2018
Engineered biodevices are demonstrating the potential to create long-term changes in neural circuits, termed neuroplasticity. The approach of engineering neuroplasticity is rapidly expanding, building on recent demonstrations of improved quality of life for people with movement disorders, epilepsy, and spinal cord injury. Discovering the fundamental mechanisms of engineered neuroplasticity by leveraging anatomically well-documented systems like the spinal cord is likely to provide powerful insights into solutions for other neurotraumas.
Given recent breakthroughs, clinical translation can be unusually short, with multisite trials of transcutaneous spinal stimulation already beginning and potential availability in 2-3 years.
The greatest benefit of engineered neuroplasticity may be realized in combination with biological and pharmacological therapies to produce targeted and robust regeneration of neural circuits.
The spinal cord after injury offers a tractable anatomical model of CNS repair, potentially impacting new treatment options for other neurological disorders.